Form 4 filed by MURPHY ANDREW J
MURPHY ANDREW J filed this Form 4 on REGN (REGENERON PHARMACEUTICALS, INC.) with 30 transaction rows and 1 holding row, accepted by EDGAR 2026-10-15 20:02:50 UTC.
- Accession
- 0001796226-26-000002
- Filer
- CIK 1796226
- Filed
- 2026-10-15
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: REGN · REGENERON PHARMACEUTICALS, INC. (CIK 872589)
- MURPHY ANDREW J officer (Co-Chief Scientific Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-13 | M exercised | +17,000 | $381.92 | 64,833 | D |
| Common Stock | 2026-10-13 | F withheld for tax | -12,853 | $754.58 | 51,980 | D |
| Common Stock | 2026-10-14 | S sold | -6 | $753.76 | 51,974 | D |
| Common Stock | 2026-10-14 | S sold | -35 | $755.91 | 51,939 | D |
| Common Stock | 2026-10-14 | S sold | -16 | $757.68 | 51,923 | D |
| Common Stock | 2026-10-14 | S sold | -24 | $758.16 | 51,899 | D |
| Common Stock | 2026-10-14 | S sold | -14 | $759.96 | 51,885 | D |
| Common Stock | 2026-10-14 | S sold | -74 | $760.65 | 51,811 | D |
| Common Stock | 2026-10-14 | S sold | -27 | $761.36 | 51,784 | D |
| Common Stock | 2026-10-14 | S sold | -55 | $762.57 | 51,729 | D |
| Common Stock | 2026-10-14 | S sold | -25 | $763.76 | 51,704 | D |
| Common Stock | 2026-10-14 | S sold | -219 | $764.4 | 51,485 | D |
| Common Stock | 2026-10-14 | S sold | -271 | $765.39 | 51,214 | D |
| Common Stock | 2026-10-14 | S sold | -279 | $766.47 | 50,935 | D |
| Common Stock | 2026-10-14 | S sold | -192 | $767.39 | 50,743 | D |
| Common Stock | 2026-10-14 | S sold | -105 | $768.33 | 50,638 | D |
| Common Stock | 2026-10-14 | S sold | -127 | $769.3 | 50,511 | D |
| Common Stock | 2026-10-14 | S sold | -12 | $770.2 | 50,499 | D |
| Common Stock | 2026-10-14 | S sold | -283 | $771.56 | 50,216 | D |
| Common Stock | 2026-10-14 | S sold | -211 | $772.56 | 50,005 | D |
| Common Stock | 2026-10-14 | S sold | -224 | $773.4 | 49,781 | D |
| Common Stock | 2026-10-14 | S sold | -121 | $774.48 | 49,660 | D |
| Common Stock | 2026-10-14 | S sold | -376 | $775.46 | 49,284 | D |
| Common Stock | 2026-10-14 | S sold | -66 | $776.31 | 49,218 | D |
| Common Stock | 2026-10-14 | S sold | -38 | $777.76 | 49,180 | D |
| Common Stock | 2026-10-14 | S sold | -454 | $778.64 | 48,726 | D |
| Common Stock | 2026-10-14 | S sold | -380 | $779.59 | 48,346 | D |
| Common Stock | 2026-10-14 | S sold | -463 | $780.63 | 47,883 | D |
| Common Stock | 2026-10-14 | S sold | -50 | $781.47 | 47,833 | D |
| Common Stock holding | 4,414 | I By 401(k) Plan | ||||
| Non-Qualified Stock Option (right to buy) derivative | 2026-10-13 | M exercised | -17,000 | $0 | 17,000 | D |